Risk of <scp>new‐onset</scp> type 2 diabetes in 600 055 people after <scp>COVID</scp> ‐19: A cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of new‐onset type 2 diabetes in 600 055 people after COVID ‐19: A cohort study

Published:2022-02-15 Issue:6 Volume:24 Page:1176-1179
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Birabaharan Morgan¹^ORCID,Kaelber David C.²,Pettus Jeremy H.³,Smith Davey M.¹

Affiliation:

1. Division of Infectious Diseases and Global Public Health University of California San Diego California

2. Department of Population and Quantitative Health Sciences Case Western Reserve University School of Medicine Cleveland Ohio

3. Division of Endocrinology and Metabolism University of California San Diego California

Funder

Center for AIDS Research, University of California, San Diego

Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14659

Reference15 articles.

1. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

2. SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature

3. Viral infiltration of pancreatic islets in patients with COVID-19

4. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study

5. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID ‐19

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distribution of the T cell element of the immune system in post-COVID patients with first identified hyperglycemia;Russian Journal of Immunology;2024-08-12

2. Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes: A target trial emulation study;Diabetes, Obesity and Metabolism;2024-08-07

3. Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2;Metabolism;2024-07

4. Diabetes Following COVID-19 Infection: Is It Common?;Journal of Insurance Medicine;2024-05-28

5. COVID-19 infection and incident diabetes in American Indian and Alaska Native people: a retrospective cohort study;The Lancet Regional Health - Americas;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3